Clopidogrel-related refractory bleeding after coronary artery bypass graft surgery: A rationale for the use of coagulation factor concentrates?

Heart Surgery Forum

Volumn 8, Issue 1, 2005, Pages

  Von Heymann, Christian ^a   Schoenfeld, H ^a   Sander, M ^a   Ziemer, S ^a   Grubitzsch, H ^a   Spies, C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 13; CLOPIDOGREL; DESMOPRESSIN; FIBRINOGEN; FRESH FROZEN PLASMA; HEPARIN; PROTAMINE; RECOMBINANT ACTIVATED FACTOR 7; RECOMBINANT PROTEIN; THROMBOCYTE CONCENTRATE; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ARTICLE; CARDIOPULMONARY BYPASS; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY BYPASS GRAFT; DRUG MEGADOSE; ERYTHROCYTE CONCENTRATE; HEMOSTASIS; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; MALE; OPERATION DURATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; DRUG ADMINISTRATION SCHEDULE; FACTOR VIIA; FACTOR XIII; FIBRINOGEN; HEMORRHAGE; HEMOSTASIS, SURGICAL; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RECOMBINANT PROTEINS; REOPERATION; RETREATMENT; TICLOPIDINE; TREATMENT OUTCOME;

EID: 33745170938     PISSN: 10983511     EISSN: None     Source Type: Journal    
DOI: 10.1532/HSF98.20041122     Document Type: Article

References (11)

1. Goedje O, Haushofer M, Lamm P, Reichart B. 1998. The effect of factor XIII on bleeding in coronary surgery. Thorac Cardiovasc Surg 46:263-7.
2. Kam PCA, Nethery CM. 2003. The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments. Anaesthesia 58:28-35.
3. Ley SJ. 2001. Quality care outcomes in cardiac surgery: the role of evidence-based practice. AACN Clin Issues 12:606-17.
4. Monroe DM, Hoffmann MJ, Oliver JA, Roberts HR. 1997. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 99:542-7.
5. Moulton MJ, Creswell LL, Mackey ME, et al. 1996. Reexploration for bleeding is a risk factor adverse outcomes after cardiac operations. J Thorac Cardiovasc Surg 111:1037-46.
6. Mueller T, Haltmayer M, Poelz W, Haidinger D. 2003. Monitoring aspirin 100 mg and clopidogrel 75 mg therapy with the PFA-100 device in patients with peripheral artery disease. Vasc Endovasc Surg 37(2):117-23.
7. Sare GM, Lloyd FR, Slower MJ. 2002. Life-threatening haemorrhage after extracorporeal shockwave lithotripsy in a patient taking clopidogrel. BJU International 90;4:469.
8. Schroeder V, Chatterjee T, Kohler HP. 2001. Influence of blood coagulation factor XIII and FXIII Val34Leu on plasma clot formation measured by thrombelastography. Thromb Res 104(6):467-74.
9. Sharis PJ, Cannon CP, Loscalzo J. 1998. The antiplatelet effects of ticlopidine and clopidogrel. Ann Intern Med 129:394-405.
10. Yende S, Wunderink RG. 2001. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med 29(12):2271-5.
11. Yusuf S, Zhao F, Mehta SR, et al. 2001. Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345(7):494-502.